IRCCS San Martino Policlinic Hospital, Neuroradiology and Neurology, Genoa, Italy.
Department of NEUROFARBA, Neuroscience Section, University of Florence, Florence, Italy.
Int J Stroke. 2021 Oct;16(7):818-827. doi: 10.1177/1747493020976681. Epub 2020 Dec 6.
There are limited data concerning procedure-related complications of endovascular thrombectomy for large vessel occlusion strokes.
We evaluated the cumulative incidence, the clinical relevance in terms of increased disability and mortality, and risk factors for complications.
From January 2011 to December 2017, 4799 patients were enrolled by 36 centers in the Italian Registry of Endovascular Stroke Treatment. Data on demographic and procedural characteristics, complications, and clinical outcome at three months were prospectively collected.
The complications cumulative incidence was 201 per 1000 patients undergoing endovascular thrombectomy. Ongoing antiplatelet therapy (p < 0.01; OR 1.82, 95% CI: 1.21-2.73) and large vessel occlusion site (carotid-T, p < 0.03; OR 3.05, 95% CI: 1.13-8.19; M2-segment-MCA, p < 0.01; OR 4.54, 95% CI: 1.66-12.44) were associated with a higher risk of subarachnoid hemorrhage/arterial perforation. Thrombectomy alone (p < 0.01; OR 0.50, 95% CI: 0.31-0.83) and younger age (p < 0.04; OR 0.98, 95% CI: 0.97-0.99) revealed a lower risk of developing dissection. M2-segment-MCA occlusion (p < 0.01; OR 0.35, 95% CI: 0.19-0.64) and hypertension (p < 0.04; OR 0.77, 95% CI: 0.6-0.98) were less related to clot embolization. Higher NIHSS at onset (p < 0.01; OR 1.04, 95% CI: 1.02-1.06), longer groin-to-reperfusion time (p < 0.01; OR 1.05, 95% CI: 1.02-1.07), diabetes (p < 0.01; OR 1.67, 95% CI: 1.25-2.23), and LVO site (carotid-T, p < 0.01; OR 1.96, 95% CI: 1.26-3.05; M2-segment-MCA, p < 0.02; OR 1.62, 95% CI: 1.08-2.42) were associated with a higher risk of developing symptomatic intracerebral hemorrhage compared to no/asymptomatic intracerebral hemorrhage. The subgroup of patients treated with thrombectomy alone presented a lower risk of symptomatic intracerebral hemorrhage (p < 0.01; OR 0.70; 95% CI: 0.55-0.90). Subarachnoid hemorrhage/arterial perforation and symptomatic intracerebral hemorrhage after endovascular thrombectomy worsen both functional independence and mortality at three-month follow-up (p < 0.01). Distal embolization is associated with neurological deterioration (p < 0.01), while arterial dissection did not affect clinical outcome at follow-up.
Complications globally considered are not uncommon and may result in poor clinical outcome. Early recognition of risk factors might help to prevent complications and manage them appropriately in order to maximize endovascular thrombectomy benefits.
目前关于血管内血栓切除术治疗大血管闭塞性卒中的相关并发症数据有限。
我们评估了并发症的累积发生率、在残疾和死亡率增加方面的临床相关性,以及风险因素。
2011 年 1 月至 2017 年 12 月,36 个中心的 4799 例患者纳入意大利血管内卒中治疗登记处。前瞻性收集人口统计学和程序特征、并发症和三个月时的临床结局数据。
4799 例患者中,201 例(4.2%)发生并发症。正在进行抗血小板治疗(p<0.01;OR 1.82,95%CI:1.21-2.73)和大血管闭塞部位(颈内动脉-T,p<0.03;OR 3.05,95%CI:1.13-8.19;M2 段-MCA,p<0.01;OR 4.54,95%CI:1.66-12.44)与蛛网膜下腔出血/动脉穿孔的风险增加相关。单纯血栓切除术(p<0.01;OR 0.50,95%CI:0.31-0.83)和较年轻的年龄(p<0.04;OR 0.98,95%CI:0.97-0.99)与夹层的风险降低相关。M2 段-MCA 闭塞(p<0.01;OR 0.35,95%CI:0.19-0.64)和高血压(p<0.04;OR 0.77,95%CI:0.6-0.98)与血栓栓塞的相关性较低。发病时 NIHSS 较高(p<0.01;OR 1.04,95%CI:1.02-1.06)、股动脉至再灌注时间较长(p<0.01;OR 1.05,95%CI:1.02-1.07)、糖尿病(p<0.01;OR 1.67,95%CI:1.25-2.23)和 LVO 部位(颈内动脉-T,p<0.01;OR 1.96,95%CI:1.26-3.05;M2 段-MCA,p<0.02;OR 1.62,95%CI:1.08-2.42)与无症状性脑出血相比,发生症状性脑出血的风险更高。单独接受血栓切除术治疗的患者亚组发生症状性脑出血的风险较低(p<0.01;OR 0.70;95%CI:0.55-0.90)。血管内血栓切除术治疗后发生蛛网膜下腔出血/动脉穿孔和症状性脑出血会导致三个月随访时功能独立性和死亡率恶化(p<0.01)。远端栓塞与神经功能恶化相关(p<0.01),而动脉夹层不会影响随访时的临床结局。
总体而言,并发症并不少见,可能导致不良的临床结局。早期识别风险因素有助于预防并发症,并在发生并发症时进行适当的管理,从而最大限度地提高血管内血栓切除术的疗效。